Breaking News, Promotions & Moves

Akari Therapeutics Names Beth-Anne Lang Senior VP of Regulatory Affairs

Lang brings more than 20 years of experience in regulatory strategy, regulatory affairs, and drug development.

Akari Therapeutics, Plc., a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, appointed Beth-Anne Lang, senior vice president, regulatory Affairs. Lang has more than 20 years of experience in regulatory strategy, regulatory affairs, and drug development. Lang begins her new role at Akari on September 1, 2023. Before joining Akari, Lang was senior VP regulatory affairs and pharmacovigilance for Enzyvant Therapeutics, where she led regulato...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters